EUVIMEDEUVIMED entdecken
Crossref

Spectrum of Pediatric Malignancies Treated with Radiotherapy in NorthEast India: A Five-Year Institutional Experience

Moumita Paul, Apala Bhattacharjee, Ghritashee Bora, Goutham Raj C., Smriti Goswami, Luri Borah

International Journal of Current Pharmaceutical Review and Research · 31.05.2026 · 18 (05)

DOI: 10.25258/ijcpr.18.5.75 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 31.05.2026. Verfasst von Moumita Paul und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Childhood cancers, though relatively uncommon, represent a significant cause of morbidity and mortality worldwide. In India, where pediatric cancers constitute less than 5% of the overall cancer burden, regional disparities in access to diagnosis and treatment persist. The North-Eastern region, with its distinctive demographic and healthcare landscape, remains particularly underrepresented in pediatric oncology literature. Data on children receiving radiotherapy, an integral component of multimodal cancer care, are especially limited in this part of the country. This study was undertaken to address this gap by evaluating the clinical and demographic characteristics of pediatric cancer patients receiving radiotherapy at a tertiary care center in NorthEast India. Materials and Methods: A retrospective, cross-sectional study was conducted on pediatric patients aged 0–18 years who underwent radiotherapy between January 2019 and December 2023. Patient demographics, tumour characteristics, treatment intent, and anesthesia use were collected and analyzed descriptively.

Results

Among 94 patients analyzed, 58.5% were male and the largest age group was 14–18 years (36%). Hematological malignancies were most frequent (53.1%), predominantly B-cell acute lymphoblastic leukemia (B-ALL; 40.4%), followed by central nervous system tumours (29.7%). Prophylactic radiotherapy was delivered in 45% of cases, adjuvant in 37.2%, and definitive in 15%. Most patients were from Lower Assam (50%), and only 17% required anesthesia, reflecting good compliance among older children.

Conclusion

This study provides valuable insight into the spectrum of pediatric malignancies treated with radiotherapy in North-East India. Hematological cancers, particularly B-ALL, predominated, with prophylactic radiotherapy being the most common treatment intent. The findings underscore the urgent need to strengthen pediatric oncology infrastructure, incorporate advanced radiotherapy techniques, and develop region-specific treatment protocols to improve childhood cancer outcomes in this underserved region.

Zitieren

APA

Paul, M., Bhattacharjee, A., Bora, G., C., G. R., Goswami, S., & Borah, L. (2026). Spectrum of Pediatric Malignancies Treated with Radiotherapy in NorthEast India: A Five-Year Institutional Experience. International Journal of Current Pharmaceutical Review and Research, 18(05). https://doi.org/10.25258/ijcpr.18.5.75

Vancouver

Paul M, Bhattacharjee A, Bora G, C. GR, Goswami S, Borah L. Spectrum of Pediatric Malignancies Treated with Radiotherapy in NorthEast India: A Five-Year Institutional Experience. International Journal of Current Pharmaceutical Review and Research. 2026;18(05). doi:10.25258/ijcpr.18.5.75

BibTeX
@article{Paul2026,
  author = {Paul, Moumita and Bhattacharjee, Apala and Bora, Ghritashee and C., Goutham Raj and Goswami, Smriti and Borah, Luri},
  title = {Spectrum of Pediatric Malignancies Treated with Radiotherapy in NorthEast India: A Five-Year Institutional Experience},
  journal = {International Journal of Current Pharmaceutical Review and Research},
  year = {2026},
  volume = {18},
  number = {05},
  doi = {10.25258/ijcpr.18.5.75}
}
Kostenlos starten →